Stage 2 CTE is the second of four levels in the McKee staging system for chronic traumatic encephalopathy, a brain disease caused by repeated head impacts. At this stage, abnormal clumps of a protein called tau have spread beyond a single spot and now appear in multiple areas across the brain’s surface. It falls under what researchers classify as “Low CTE,” alongside Stage 1, meaning the disease is still in its earlier phases. Symptoms at this stage center on mood and behavior rather than memory loss.
What Happens in the Brain at Stage 2
CTE is defined by the buildup of a damaged form of tau protein around small blood vessels deep in the brain’s grooves (called sulci). In Stage 1, only one or two isolated clusters of this tau appear, typically in the frontal cortex. Stage 2 marks a meaningful jump: three or more of these tau clusters are now present across multiple regions of the cortex, specifically in the frontal, temporal, and parietal lobes and a deeper structure called the insula.
Tangles of tau also begin appearing in superficial layers of the cortex and in two small but important structures deep in the brainstem. One of these, the locus coeruleus, plays a central role in alertness and the stress response. The other, the substantia nigra, is involved in movement and reward. Damage to these areas helps explain why Stage 2 symptoms go beyond headaches or mild irritability and start affecting mood and impulse control in more noticeable ways.
Symptoms of Stage 2 CTE
The hallmark symptoms at this stage are behavioral outbursts and more severe depression. People in Stage 1 may experience headaches and subtle mood changes, but Stage 2 is where emotional and behavioral problems become harder to ignore. Explosive anger, impulsivity, and deepening depressive episodes are characteristic.
Notably, significant memory loss and problems with planning or decision-making (executive function) are not yet typical at this stage. Those cognitive symptoms tend to appear later, around Stage 3. This distinction matters because someone with Stage 2 CTE may seem cognitively sharp while struggling with emotional regulation, which can make the condition easy to misattribute to a psychiatric disorder rather than a neurodegenerative one.
Who Gets Diagnosed at Stage 2
Research from Boston University found that among football players, the stages of CTE pathology are significantly associated with age at death, total years of playing, and time elapsed after retirement. The disease continues to progress even after exposure to head impacts stops, suggesting that tau keeps spreading on its own once it reaches a certain threshold.
Individuals who present with the mood and behavioral symptoms characteristic of Stage 2 disease have an average age of about 35. That’s roughly two decades younger than those who present with the memory and executive dysfunction of Stage 3, whose average age is around 54. This gap supports the idea that CTE follows a predictable path: emotional symptoms come first, cognitive decline follows years later.
How Stage 2 Differs From Later Stages
Stages 1 and 2 are grouped together as “Low CTE,” while Stages 3 and 4 are classified as “High CTE.” The practical difference is substantial. In Low CTE, tau is limited to scattered clusters in the cortex and a couple of brainstem nuclei. By Stage 3, tau has spread more widely and cognitive symptoms like memory loss take hold. By Stage 4, tau is widespread throughout the brain, and individuals typically experience severe dementia.
The transition from Stage 2 to Stage 3 is not well mapped in terms of timeline. Researchers have not pinpointed how many years a person typically remains at Stage 2 before progressing. What is known is that the spread of tau correlates with cumulative years of head impact exposure, and that progression continues after the person has stopped playing contact sports.
Why It Can Only Be Confirmed After Death
CTE at any stage can currently only be diagnosed definitively through autopsy. A neuropathologist examines brain tissue under a microscope, looking for the specific pattern of tau buildup around blood vessels at the base of the brain’s grooves. No blood test, brain scan, or clinical exam can confirm it in a living person.
That said, progress is being made. Researchers at Boston University used an experimental PET scan (a type of brain imaging) to detect tau buildup in living former NFL players. The scan found elevated tau without the amyloid protein buildup you’d expect in Alzheimer’s, a pattern consistent with CTE. However, the results only held up at the group level. As of now, the technique cannot tell whether any single individual has CTE. The research team has expressed optimism that a reliable living diagnosis could become possible within the next several years, but it is not available yet.
Managing Stage 2 Symptoms
There is no treatment that stops or reverses CTE. Management focuses entirely on easing symptoms and preserving quality of life. For the depression and behavioral changes typical of Stage 2, careful psychiatric support is important, particularly because of the elevated risk of suicidal thinking that accompanies CTE-related depression.
Cognitive rehabilitation therapy, regular aerobic exercise, and a Mediterranean-style diet have all shown potential for supporting brain function. Occupational rehabilitation can help people maintain daily routines and work capacity. Some medications may help with cognitive and memory symptoms as the disease progresses, though their benefit at Stage 2 specifically is not well established. The overall approach is multidisciplinary: combining mental health support, lifestyle changes, and practical rehabilitation to manage what is, for now, an irreversible condition.